Bipolar Disorder is the sixth leading cause of disability in the United States and asserts broad negative effects on the patient's psychological and psychosocial functioning. Variations in its presentation at different times in the life cycle make Bipolar Disorder a difficult condition to recognize and, therefore, a challenge to treat. In particular the co-occurrence of mania and attention deficit hyperactivity disorder in children is difficult to interpret clinically. In this program, the first randomized, controlled trial using an adjunctive atypical antipsychotic in the treatment of adolescent mania will be described. Also includes a syllabus and course guide.